The S&P 500 increased by almost 5% in the past week, the market is recovering from losses earlier this year. Much fewer companies make new lows. Last week’s top five out of favor companies were AstraZeneca PLC, Steris Corp, Wyeth, Avid Technology Inc, and Novartis AG.
Pharmaceuticals and Biotechnology has replaced banking as the top out of favor industry, and has 16 stocks reaching their 52-week lows, 12 reaching their 52-week high and a low/high ratio of 1.33. It is followed by the Oil industry, which has 2 stocks reaching their 52-week lows and 2 reaching their 52-week high. The industry has a low/high ratio of 1.
For more details about 52-week low companies, click here: http://www.gurufocus.com/52weelow.php.
AstraZeneca PLC (AZN, Financial) Reached the 52-Week Low of 41.25
The prices of AstraZeneca PLC (AZN) shares have declined to close the 52-week low of $41.25, which is 27.7% off the 52-week high of $59.47. The company is owned by 3 Gurus we are tracking.
AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. AstraZeneca PLC has a market cap of $69.47 billion; its shares were traded at around $41.25 with P/E ratio of 11.38 and P/S ratio of 2.99. The dividend yield of AstraZeneca PLC stocks is 4.1%.
AstraZeneca has been accused of violating the U.N.'s oil-for-food program, established in around 1990 by Britain's Serious Fraud Office to relieve the impact on Iraqis of after Saddam Hussein’s 1990 invasion of Kuwait.
AstraZeneca PLC is owned by 3 Gurus. Among them, 2 have added to their positions during the past quarter. Edward Owens left his positions unchanged. Charles Brandes owns 13,930,618 shares as of 09/30/2007, an increase of 26.91% from the previous quarter. This position accounts for 1.27% of the $54.85 billion portfolio of Brandes Investment. Kenneth Fisher owns 5,876,175 shares as of 09/30/2007, which accounts for 0.79% of the $37.1 billion portfolio of Fisher Asset Management, LLC.
Steris Corp. (STE, Financial) Reached the 52-Week Low of $24.74
Steris Corp has reached its 52-week low of $24.72, which is 22.3% lower than its 52-week high of $31.71. It is owned by 5 gurus that we are tracking.
The company creates and manufactures contamination control, surgical and critical care products and provides other related services. The company has a market cap of $1.56 billion and a dividend yield of 0.9%.It has a P/E ratio 19.92 and P/S ratio of 1.26.
Shares of Steris Corp. fell to an annual low after it lowered its full-year 2008 earnings guidance due to slower than expected production levels at its New Mexico manufacturing plant.
5 gurus currently own Steris Corp. Among them, 1 is a new holder of the company, 2 increased their positions, 1 left them unchanged and 1 reduced their positions.
George Soros bought 9,746 shares in the quarter ended 09/30/2007 , which accounts for 0.01% of the $2.91 billion portfolio of Soros Fund Management LLC. Richard Aster Jr. owns 889,000 shares as of 09/30/2007 , an increase of 28.62% from the previous quarter. This position accounts for 0.66% of the $3.7 billion portfolio of Meridian Fund.
Mark D Mcginley, the Sr. VP, Gen Counsel, and Sec. of Steris Corp bought 1,000 shares of STE stock on 09/20/2007 at the average price of $26.92. The price of the stock has decreased by 8.1% since.
Wyeth (WYE, Financial) Reached the 52-Week Low of 41.05
The prices of Wyeth (WYE) shares have declined to the 52-week low of $41.05, which is 30.0% off the 52-week high of $62.2. Wyeth is owned by 9 Gurus we are tracking. Among them, 5 have added to their positions during the past quarter. 4 reduced their positions.
Wyeth engages in the discovery, development, manufacture, distribution, and sale of pharmaceuticals, consumer healthcare, and animal health products. It operates through three segments: Pharmaceuticals, Consumer Healthcare, and Animal Health. Wyeth has a market cap of $58.71 billion; its shares were traded at around $43.84 with a P/E ratio of 13.46 and P/S ratio of 2.71. The dividend yield of Wyeth stocks is 2.6%.
Wyeth’s would-be blockbuster drugs are being delayed or denied by the Food and Drug Administration. They have reduced the number of drugs being accepted and is frequently sending Wyeth back to the lab for more safety studies since the drug Vloxx was discovered to be linked to heart attack and stroke in 2004. Questions about the effectiveness of some antidepressants also hurt the company.
Irving Kahn owns 574,138 shares as of 09/30/2007 , an increase of 61.03% from the previous quarter. This position accounts for 4.19% of the $611 million portfolio of Kahn Brothers & Company Inc.. David Dreman owns 10,898,368 shares as of 09/30/2007 , an increase of 24.15% from the previous quarter. This position accounts for 2.86% of the $18.4 billion portfolio of Dreman Value Management. Brian Rogers owns 4,476,000 shares as of 12/31/2007 , which accounts for 0.85% of the $21.43 billion portfolio of T Rowe Price Equity Income Fund.
George Soros sold out his holdings in the quarter ended 09/30/2007 .
Sr. VP- Human Resources Rene R Lewin sold 9,848 shares of WYE stock on 10/26/2007 at the average price of $49.04, the price of the stock has decreased by 10.6% since.
Avid Technology Inc. (AVID, Financial) Reached the 52-Week Low of $20.88
The prices of Avid Technology Inc. (AVID) shares have declined to close the 52-week low of $20.88, which is 39.4% off the 52-week high of $38.78.
Avid Technology, Inc. develops and markets digital media content. The company has a market cap of $857.4 million and a P/S ratio of 1.17.
Avid technology has reached its lowest points since 2003, which is its 5-year low. Analysts downgraded the stock from a “hold” to a “sell” rating.
Avid Technology Inc. is owned by 3 Gurus. All of them increased their positions in AVID.
Richard Aster Jr. owns 677,400 shares as of 09/30/2007 , an increase of 26.52% from the previous quarter. This position accounts for 0.5% of the $3.7 billion portfolio of Meridian Fund. David Dreman owns 329,500 shares as of 09/30/2007 , an increase of 14.37% from the previous quarter. This position accounts for 0.05% of the $18.4 billion portfolio of Dreman Value Management. Bruce Sherman owns 5,645,086 shares as of 09/30/2007 , which accounts for 0.8% of the $19.18 billion portfolio of Private Capital Management.
Ruane Cunniff sold out his holdings in the quarter that ended on 09/30/2007 .
Novartis AG (NVS, Financial) Reached the 52-Week Low of 50.43
The prices of Novartis AG (NVS) shares have declined to the 52-week low of $50.43, which is 17.4% off the 52-week high of $60.36. The company provides healthcare solutions that address the needs of patients and societies worldwide. It has a market cap of $113.77 billion and was last traded at around $50.43 with a P/E ratio of 9.79 and P/S ratio of 2.98. The dividend yield of Novartis AG stocks is 1.9%.
Novartis said outsourcing played a role in cutting $700 million of cost between 2006 and 2007. Some investors may worry that all Novartis is doing is using its strong balance sheet to keep them happy as it struggles against a growing list of problems that threaten to stagger sales and earnings growth.
Novartis AG is owned by 8 Gurus. Among them, 4 have added to their positions during the past quarter and 2 initiated positions in NVS. 1 reduced his position, and 1 left them unchanged.
Jean-Marie Eveillard bought 13,200 shares in the quarter ending 09/30/2007 , which accounts for 0.01% of the $13.02 billion portfolio of his portfolio. John Keeley bought 5,000 shares in the quarter ending 09/30/2007 , which accounts for less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
Dodge & Cox owns 70,523,550 shares as of 09/30/2007 , an increase of 47.15% from the previous quarter. This position accounts for 2.83% of the $136.79 billion portfolio of Dodge & Cox. Charles Brandes owns 325,500 shares as of 09/30/2007 , an increase of 308.38% from the previous quarter. This position accounts for 0.03% of the $54.85 billion portfolio of Brandes Investment. Edward Owens owns 13,219,880 shares as of 09/30/2007 , which accounts for 2.88% of the $25.21 billion portfolio of Vanguard Health Care Fund.
David Dreman sold out his holdings in the quarter ending 09/
Pharmaceuticals and Biotechnology has replaced banking as the top out of favor industry, and has 16 stocks reaching their 52-week lows, 12 reaching their 52-week high and a low/high ratio of 1.33. It is followed by the Oil industry, which has 2 stocks reaching their 52-week lows and 2 reaching their 52-week high. The industry has a low/high ratio of 1.
For more details about 52-week low companies, click here: http://www.gurufocus.com/52weelow.php.
AstraZeneca PLC (AZN, Financial) Reached the 52-Week Low of 41.25
The prices of AstraZeneca PLC (AZN) shares have declined to close the 52-week low of $41.25, which is 27.7% off the 52-week high of $59.47. The company is owned by 3 Gurus we are tracking.
AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. AstraZeneca PLC has a market cap of $69.47 billion; its shares were traded at around $41.25 with P/E ratio of 11.38 and P/S ratio of 2.99. The dividend yield of AstraZeneca PLC stocks is 4.1%.
AstraZeneca has been accused of violating the U.N.'s oil-for-food program, established in around 1990 by Britain's Serious Fraud Office to relieve the impact on Iraqis of after Saddam Hussein’s 1990 invasion of Kuwait.
AstraZeneca PLC is owned by 3 Gurus. Among them, 2 have added to their positions during the past quarter. Edward Owens left his positions unchanged. Charles Brandes owns 13,930,618 shares as of 09/30/2007, an increase of 26.91% from the previous quarter. This position accounts for 1.27% of the $54.85 billion portfolio of Brandes Investment. Kenneth Fisher owns 5,876,175 shares as of 09/30/2007, which accounts for 0.79% of the $37.1 billion portfolio of Fisher Asset Management, LLC.
Steris Corp. (STE, Financial) Reached the 52-Week Low of $24.74
Steris Corp has reached its 52-week low of $24.72, which is 22.3% lower than its 52-week high of $31.71. It is owned by 5 gurus that we are tracking.
The company creates and manufactures contamination control, surgical and critical care products and provides other related services. The company has a market cap of $1.56 billion and a dividend yield of 0.9%.It has a P/E ratio 19.92 and P/S ratio of 1.26.
Shares of Steris Corp. fell to an annual low after it lowered its full-year 2008 earnings guidance due to slower than expected production levels at its New Mexico manufacturing plant.
5 gurus currently own Steris Corp. Among them, 1 is a new holder of the company, 2 increased their positions, 1 left them unchanged and 1 reduced their positions.
George Soros bought 9,746 shares in the quarter ended 09/30/2007 , which accounts for 0.01% of the $2.91 billion portfolio of Soros Fund Management LLC. Richard Aster Jr. owns 889,000 shares as of 09/30/2007 , an increase of 28.62% from the previous quarter. This position accounts for 0.66% of the $3.7 billion portfolio of Meridian Fund.
Mark D Mcginley, the Sr. VP, Gen Counsel, and Sec. of Steris Corp bought 1,000 shares of STE stock on 09/20/2007 at the average price of $26.92. The price of the stock has decreased by 8.1% since.
Wyeth (WYE, Financial) Reached the 52-Week Low of 41.05
The prices of Wyeth (WYE) shares have declined to the 52-week low of $41.05, which is 30.0% off the 52-week high of $62.2. Wyeth is owned by 9 Gurus we are tracking. Among them, 5 have added to their positions during the past quarter. 4 reduced their positions.
Wyeth engages in the discovery, development, manufacture, distribution, and sale of pharmaceuticals, consumer healthcare, and animal health products. It operates through three segments: Pharmaceuticals, Consumer Healthcare, and Animal Health. Wyeth has a market cap of $58.71 billion; its shares were traded at around $43.84 with a P/E ratio of 13.46 and P/S ratio of 2.71. The dividend yield of Wyeth stocks is 2.6%.
Wyeth’s would-be blockbuster drugs are being delayed or denied by the Food and Drug Administration. They have reduced the number of drugs being accepted and is frequently sending Wyeth back to the lab for more safety studies since the drug Vloxx was discovered to be linked to heart attack and stroke in 2004. Questions about the effectiveness of some antidepressants also hurt the company.
Irving Kahn owns 574,138 shares as of 09/30/2007 , an increase of 61.03% from the previous quarter. This position accounts for 4.19% of the $611 million portfolio of Kahn Brothers & Company Inc.. David Dreman owns 10,898,368 shares as of 09/30/2007 , an increase of 24.15% from the previous quarter. This position accounts for 2.86% of the $18.4 billion portfolio of Dreman Value Management. Brian Rogers owns 4,476,000 shares as of 12/31/2007 , which accounts for 0.85% of the $21.43 billion portfolio of T Rowe Price Equity Income Fund.
George Soros sold out his holdings in the quarter ended 09/30/2007 .
Sr. VP- Human Resources Rene R Lewin sold 9,848 shares of WYE stock on 10/26/2007 at the average price of $49.04, the price of the stock has decreased by 10.6% since.
Avid Technology Inc. (AVID, Financial) Reached the 52-Week Low of $20.88
The prices of Avid Technology Inc. (AVID) shares have declined to close the 52-week low of $20.88, which is 39.4% off the 52-week high of $38.78.
Avid Technology, Inc. develops and markets digital media content. The company has a market cap of $857.4 million and a P/S ratio of 1.17.
Avid technology has reached its lowest points since 2003, which is its 5-year low. Analysts downgraded the stock from a “hold” to a “sell” rating.
Avid Technology Inc. is owned by 3 Gurus. All of them increased their positions in AVID.
Richard Aster Jr. owns 677,400 shares as of 09/30/2007 , an increase of 26.52% from the previous quarter. This position accounts for 0.5% of the $3.7 billion portfolio of Meridian Fund. David Dreman owns 329,500 shares as of 09/30/2007 , an increase of 14.37% from the previous quarter. This position accounts for 0.05% of the $18.4 billion portfolio of Dreman Value Management. Bruce Sherman owns 5,645,086 shares as of 09/30/2007 , which accounts for 0.8% of the $19.18 billion portfolio of Private Capital Management.
Ruane Cunniff sold out his holdings in the quarter that ended on 09/30/2007 .
Novartis AG (NVS, Financial) Reached the 52-Week Low of 50.43
The prices of Novartis AG (NVS) shares have declined to the 52-week low of $50.43, which is 17.4% off the 52-week high of $60.36. The company provides healthcare solutions that address the needs of patients and societies worldwide. It has a market cap of $113.77 billion and was last traded at around $50.43 with a P/E ratio of 9.79 and P/S ratio of 2.98. The dividend yield of Novartis AG stocks is 1.9%.
Novartis said outsourcing played a role in cutting $700 million of cost between 2006 and 2007. Some investors may worry that all Novartis is doing is using its strong balance sheet to keep them happy as it struggles against a growing list of problems that threaten to stagger sales and earnings growth.
Novartis AG is owned by 8 Gurus. Among them, 4 have added to their positions during the past quarter and 2 initiated positions in NVS. 1 reduced his position, and 1 left them unchanged.
Jean-Marie Eveillard bought 13,200 shares in the quarter ending 09/30/2007 , which accounts for 0.01% of the $13.02 billion portfolio of his portfolio. John Keeley bought 5,000 shares in the quarter ending 09/30/2007 , which accounts for less than 0.01% of the $8.95 billion portfolio of Keeley Fund Management.
Dodge & Cox owns 70,523,550 shares as of 09/30/2007 , an increase of 47.15% from the previous quarter. This position accounts for 2.83% of the $136.79 billion portfolio of Dodge & Cox. Charles Brandes owns 325,500 shares as of 09/30/2007 , an increase of 308.38% from the previous quarter. This position accounts for 0.03% of the $54.85 billion portfolio of Brandes Investment. Edward Owens owns 13,219,880 shares as of 09/30/2007 , which accounts for 2.88% of the $25.21 billion portfolio of Vanguard Health Care Fund.
David Dreman sold out his holdings in the quarter ending 09/
